Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

August 23, 2023

Study Completion Date

August 23, 2023

Conditions
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney DiseasesHealthy
Trial Locations (1)

01801

Sanguine Biosciences, Inc., Woburn

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Sanguine Biosciences

INDUSTRY